[HTML][HTML] Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa …

I Lopez-Montesinos, MM Montero, S Domene-Ochoa… - Antibiotics, 2022 - mdpi.com
This study correlates in vivo findings in a patient with an extensively drug-resistant (XDR) P.
aeruginosa infection who developed resistance to ceftazidime-avibactam (CAZ-AVI) with in …

Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa: In Vivo …

I Lopez-Montesinos, MM Montero… - Antibiotics (Basel …, 2022 - pubmed.ncbi.nlm.nih.gov
This study correlates in vivo findings in a patient with an extensively drug-resistant (XDR) P.
aeruginosa infection who developed resistance to ceftazidime-avibactam (CAZ-AVI) with in …

Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa: In Vivo …

I Lopez-Montesinos, MM Montero… - Antibiotics (2079 …, 2022 - search.ebscohost.com
This study correlates in vivo findings in a patient with an extensively drug-resistant (XDR) P.
aeruginosa infection who developed resistance to ceftazidime-avibactam (CAZ-AVI) with in …

[HTML][HTML] Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa …

I Lopez-Montesinos, MM Montero, S Domene-Ochoa… - Antibiotics, 2022 - ncbi.nlm.nih.gov
This study correlates in vivo findings in a patient with an extensively drug-resistant (XDR) P.
aeruginosa infection who developed resistance to ceftazidime-avibactam (CAZ-AVI) with in …

Suboptimal concentrations of ceftazidime/avibactam (CAZ-AVI) may select for CAZ-AVI resistance in extensively drug-resistant pseudomonas aeruginosa. in vivo and …

I López Montesinos, MM Montero, S Domene Ochoa… - 2022 - repositori.upf.edu
This study correlates in vivo findings in a patient with an extensively drug-resistant (XDR) P.
aeruginosa infection who developed resistance to ceftazidime-avibactam (CAZ-AVI) with in …

Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa: In Vivo …

I Lopez-Montesinos, MM Montero… - …, 2022 - search.proquest.com
This study correlates in vivo findings in a patient with an extensively drug-resistant (XDR) P.
aeruginosa infection who developed resistance to ceftazidime-avibactam (CAZ-AVI) with in …

Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa: In Vivo …

I Lopez-Montesinos, MM Montero… - Antibiotics (Basel …, 2022 - europepmc.org
This study correlates in vivo findings in a patient with an extensively drug-resistant (XDR) P.
aeruginosa infection who developed resistance to ceftazidime-avibactam (CAZ-AVI) with in …

[引用][C] Suboptimal concentrations of Ceftazidime/Avibactam (CAZ-AVI) may select for CAZ-AVI resistance in extensively drug-resistant Pseudomonas aeruginosa: in …

I Lopez-Montesinos, MM Montero… - …, 2022 - espace.library.uq.edu.au
This study correlates in vivo findings in a patient with an extensively drug-resistant (XDR) P.
aeruginosa infection who developed resistance to ceftazidime-avibactam (CAZ-AVI) with in …

Suboptimal concentrations of ceftazidime/avibactam (CAZ-AVI) may select for CAZ-AVI resistance in extensively drug-resistant Pseudomonas aeruginosa: in vivo and …

I Lopez-Montesinos, MM Montero, S Domene-Ochoa… - 2022 - cabidigitallibrary.org
This study correlates in vivo findings in a patient with an extensively drug-resistant (XDR) P.
aeruginosa infection who developed resistance to ceftazidime-avibactam (CAZ-AVI) with in …

[PDF][PDF] Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa …

I Lopez-Montesinos, MM Montero, S Domene-Ochoa… - 2022 - pdfs.semanticscholar.org
This study correlates in vivo findings in a patient with an extensively drug-resistant (XDR) P.
aeruginosa infection who developed resistance to ceftazidime-avibactam (CAZ-AVI) with in …